Compumedics Limited (ASX:CMP)

Market Cap	66.42M +33.0%
Revenue (ttm)	58.49M +23.5%
Net Income	113.00K
EPS	0.00
Shares Out	199.76M
PE Ratio	587.79
Forward PE	22.17
Dividend	n/a
Ex-Dividend Date	n/a

Volume	63,178
Average Volume	95,861
Open	0.3300
Previous Close	0.3325
Day's Range	0.3200 - 0.3300
52-Week Range	0.2400 - 0.4500
Beta	0.28
RSI	41.63
Earnings Date	Feb 22, 2026

About Compumedics

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory stud...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 175
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CMP

Financial Performance

In fiscal year 2025, Compumedics's revenue was 51.04 million, an increase of 1.55% compared to the previous year's 50.26 million. Losses were -1.27 million, 275.1% more than in 2024.